We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Explainer on product information templates to be used by applicants and Marketing Authorisation Holders (MAHs) of veterinary medicines.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Use a separate statement of objection form for each Japanese GI product name you object to.
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
How to prepare for implementation and compliance of the Safety Features Regulation.
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
Use this form to notify the IPO of marketing authorisation for a medicinal or plant protection product, granted after your application for an SPC for that product.
Guidance on the Specific Batch Control (SBC) scheme for release of product on to the UK market.
The actions to take for sourcing medicines in different circumstances.
Published standards for regulatory work 2023/24
Section (SPP0.01 - SPP21.01) last updated: October 2022.
Section last updated: April 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).